These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 14595043

  • 1. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
    Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT, Vaccine Safety Datalink Team.
    Pediatrics; 2003 Nov; 112(5):1039-48. PubMed ID: 14595043
    [Abstract] [Full Text] [Related]

  • 2. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B.
    Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
    [Abstract] [Full Text] [Related]

  • 3. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
    Young HA, Geier DA, Geier MR.
    J Neurol Sci; 2008 Aug 15; 271(1-2):110-8. PubMed ID: 18482737
    [Abstract] [Full Text] [Related]

  • 4. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
    Geier DA, Geier MR.
    Med Sci Monit; 2005 Apr 15; 11(4):CR160-70. PubMed ID: 15795695
    [Abstract] [Full Text] [Related]

  • 5. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
    Geier D, Geier MR.
    Int J Toxicol; 2004 Apr 15; 23(6):369-76. PubMed ID: 15764492
    [Abstract] [Full Text] [Related]

  • 6. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J, Golding J, ALSPAC Study Team.
    Pediatrics; 2004 Sep 15; 114(3):577-83. PubMed ID: 15342824
    [Abstract] [Full Text] [Related]

  • 7. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F, Vaccine Safety Datalink Team.
    N Engl J Med; 2007 Sep 27; 357(13):1281-92. PubMed ID: 17898097
    [Abstract] [Full Text] [Related]

  • 8. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
    Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D'Elia L, Chiarotti F, Salmaso S.
    Pediatrics; 2009 Feb 27; 123(2):475-82. PubMed ID: 19171612
    [Abstract] [Full Text] [Related]

  • 9. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F.
    Pediatrics; 2010 Oct 27; 126(4):656-64. PubMed ID: 20837594
    [Abstract] [Full Text] [Related]

  • 10. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK, Schwartz B, Todd J, Pickering LK.
    Pediatrics; 2004 Sep 27; 114(3):793-804. PubMed ID: 15342856
    [Abstract] [Full Text] [Related]

  • 11. [Lack of association between thimerosal-containing vaccines and autism].
    Mrozek-Budzyn D, Majewska R, Kiełtyka A, Augustyniak M.
    Przegl Epidemiol; 2011 Sep 27; 65(3):491-5. PubMed ID: 22184954
    [Abstract] [Full Text] [Related]

  • 12. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    Dórea JG, Marques RC, Brandão KG.
    Am J Perinatol; 2009 Aug 27; 26(7):523-7. PubMed ID: 19283656
    [Abstract] [Full Text] [Related]

  • 13. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S, Begier EM, Schech SD, Venus P, Shatin D, Braun MM, Ball R.
    Pediatr Infect Dis J; 2007 Apr 27; 26(4):329-33. PubMed ID: 17414397
    [Abstract] [Full Text] [Related]

  • 14. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants.
    Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O.
    Acta Paediatr; 2007 Jun 27; 96(6):864-8. PubMed ID: 17465985
    [Abstract] [Full Text] [Related]

  • 15. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar 27; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 16. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
    Geier DA, Geier MR.
    Pediatr Rehabil; 2003 Mar 27; 6(2):97-102. PubMed ID: 14534046
    [Abstract] [Full Text] [Related]

  • 17. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
    Marques RC, Dórea JG, Bernardi JV.
    Acta Paediatr; 2010 Jun 27; 99(6):934-9. PubMed ID: 20003103
    [Abstract] [Full Text] [Related]

  • 18. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
    Geier DA, Geier MR.
    Med Sci Monit; 2004 Mar 27; 10(3):PI33-9. PubMed ID: 14976450
    [Abstract] [Full Text] [Related]

  • 19. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J.
    Pediatrics; 2008 Feb 27; 121(2):e208-14. PubMed ID: 18245396
    [Abstract] [Full Text] [Related]

  • 20. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.
    Geier MR, Geier DA.
    Exp Biol Med (Maywood); 2003 Jun 27; 228(6):660-4. PubMed ID: 12773696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.